EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model

Junpeng Ma, Mingkun Wang, Kunnan Wang, Juyi Wen, Xiaoya Liu, Xiangfei Zhao

ImmunoTargets and Therapy · 2026-06 · Volume 15 · 1-16

DOI: 10.2147/itt.s597338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-06. Verfasst von Junpeng Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Uni…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

MSS Murine ModelPD-1/PD-L1-IN-9 hydrochlorideanlotinibcolorectal cancertumor immune microenvironment

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, People's Republic of China.
  • Department of Hepatobiliary Intervention, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, People's Republic of China.
  • Yttrium-90 Precision Interventional Radiotherapy Center, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Changgung Hospital, Tsinghua University, Beijing, People's Republic of China.
  • Navy Clinical College, the Fifth School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Department of General Surgery, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.

Zitieren

APA

Ma, J., Wang, M., Wang, K., Wen, J., Liu, X., & Zhao, X. (2026). Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model. ImmunoTargets and Therapy, Volume 15, 1-16. https://doi.org/10.2147/itt.s597338

Vancouver

Ma J, Wang M, Wang K, Wen J, Liu X, Zhao X. Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model. ImmunoTargets and Therapy. 2026;Volume 15:1-16. doi:10.2147/itt.s597338

BibTeX
@article{Ma2026,
  author = {Ma, Junpeng and Wang, Mingkun and Wang, Kunnan and Wen, Juyi and Liu, Xiaoya and Zhao, Xiangfei},
  title = {Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--16},
  doi = {10.2147/itt.s597338}
}
Kostenlos starten →